Pancreatic Cancer

Latest News

Data from the phase 3 TIGeR-PaC trial indicates that patients with locally advanced pancreatic cancer experienced notable survival benefit with RenovoGem vs chemotherapy
RenovoGem Provides Survival Benefit, Reduces Toxicity in Pancreatic Cancer

March 31st 2023

Data from the phase 3 TIGeR-PaC trial indicates that patients with locally advanced pancreatic cancer experienced notable survival benefit with RenovoGem vs chemotherapy.

 Results from the phase 1/2 CodeBreaK 100 trial indicate that sotorasib yields positive anticancer activity and safety in patients with pancreatic cancer harboring KRAS p.G12C mutations.
Sotorasib Demonstrates Anticancer Activity in KRAS p.G12C+ Pancreatic Cancer

January 30th 2023

Adjuvant chemotherapy following multiagent neoadjuvant chemotherapy and surgical resection produced better overall survival among patients with pancreatic ductal adenocarcinoma vs those who did not receive adjuvant treatment.
Adjuvant Chemo After Neoadjuvant Chemo/Surgery Linked With Survival in PDAC

January 27th 2023

Investigators report evidence of early efficacy with SEA-CD40, chemotherapy, and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma.
SEA-CD40/Chemo Combo Yields Anti-Tumor Efficacy in PDAC

January 21st 2023

A combination of liposomal irinotecan plus 5-fluorouracil, leucovorin, and oxaliplatin in the frontline yields a statistically significant survival benefit compared with nab-paclitaxel and gemcitabine in a population diagnosed with metastatic pancreatic ductal adenocarcinoma.
Liposomal Irinotecan and NALIRIFOX Delivers Frontline Benefit in Metastatic PDAC

January 21st 2023

Latest CME Events & Activities

Community Practice Connections™: Pathology Oncology Collaborative: Biomarker Testing in an Emerging Era of HER2 Across Breast, GI, and Lung Cancers

View More

2nd Annual Virtual Tumor Board®: Integrating Emerging Testing Methodologies into Optimal Treatment Planning in Gastrointestinal Cancers

View More

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

20th Annual Meeting of the International Society of Gastrointestinal Oncology®

10/13/2023-10/14/2023

View More

Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes

View More

Clinical Vignettes: 40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

View More

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

View More

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

View More

Medical Crossfire®: Multidisciplinary Strategies to Leverage Clinical Advances on Immune-Based Therapies for Patients with Hepatocellular Carcinoma

View More

8th Annual School of Gastrointestinal Oncology® (SOGO®)

05/06/23 8:00 AM – 5:00 PM EDT

View More

Expert Illustrations & Commentaries™: Targeting FGFR2b Overexpression in Advanced Gastric and GEJ Cancers

View More

Community Practice Connections™: Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

View More

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

View More

Advances In™: The Role of NRG1 Fusions Across Tumor Types

View More

Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

View More

Community Practice Connections™: 7th Annual School of Gastrointestinal Oncology®

View More

Addressing Racial and Ethnic Disparities in Breast Cancer Care: Improving Outcomes Across the Spectrum of Diagnosis, Trial Access, and Patient Care

View More